UiPath (NYSE: PATH) shares edged higher on Tuesday as investors continued to move past the sharp selloff triggered by OpenAI’s new enterprise agent product, while attention shifted toward whether the automation software company can sustain annual recurring revenue growth. The stock closed at $12.19, up 4.9% for the session, and remained slightly above the level seen before OpenAI introduced Presence, a platform designed to connect AI voice and chat agents with enterprise systems, policies, and human oversight.

The rebound erased the decline that followed the OpenAI announcement. UiPath fell more than 11% on the day Presence was unveiled and extended those losses in the next session. Over the past two trading days, however, the stock recovered 12.5%, suggesting the market is no longer pricing in an immediate disruption to UiPath’s business.

Recovery Outpaces the Initial Selloff

The stronger share price came without any new corporate filing, earnings update, or major announcement from UiPath. That has led many traders to conclude that positioning played a meaningful role in the rebound. Trading volume reached 46.8 million shares, still below the stock’s recent average, indicating that participation was not especially broad.

OpenAI’s Presence product enters an area adjacent to UiPath’s automation and orchestration business, and the initial market reaction reflected concern that large language model providers could increasingly compete for enterprise workflow spending. As those fears eased, investors appeared more willing to reassess the company’s longer-term position rather than focus only on the headline risk.

Short Interest Keeps Volatility Elevated

Another factor supporting the recovery is UiPath’s unusually high short interest. About 112.9 million shares were sold short in mid-July, representing nearly 29% of the public float. Reported short interest had declined from the prior period, suggesting that some bearish positions may already have been reduced.

When a heavily shorted stock begins to rise, short sellers often buy back shares to limit losses, which can intensify upward moves. Available data cannot confirm how much short covering occurred during the recent rebound, but the setup increases the potential for sharp price swings in either direction.

ARR Becomes the Key Test

The more important debate now centers on annual recurring revenue, or ARR, which many software investors view as the clearest indicator of future revenue strength. For UiPath, that makes the next update less about the day-to-day share move and more about whether its subscription base is still expanding at a pace that can support the company’s longer-term automation story.

UiPath’s second-quarter guidance points to a slower pace of expansion than the company delivered in the first quarter. Revenue is expected to come in at $395 million to $400 million, compared with $418 million in the prior quarter. Ending ARR is projected at $1.929 billion to $1.934 billion, up modestly from $1.901 billion. Implied net-new ARR is about $28 million to $33 million, versus $49 million previously, while non-GAAP operating income is expected to decline to roughly $75 million from $92 million.

At the midpoint of guidance, net-new ARR would be about 38% lower than in the first quarter, making subscription growth the central issue for investors.